JP
Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
AlphaLISA Unconjugated Acceptor Beads, 5 mg
AlphaLISA Unconjugated Acceptor Beads, 5 mg
AlphaLISA Acceptor Bead Unconjugated
Product variants
Unit Size: 1 mg
Part #:
6772001
Unit Size: 5 mg
Part #:
6772002
Unit Size: 50 mg
Part #:
6772003
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption, and disposal requirements under European REACH regulations (EC 1907/2006).
AlphaLISA Unconjugated Acceptor Beads, 5 mg
AlphaLISA Acceptor Bead Unconjugated
AlphaLISA Unconjugated Acceptor Beads, 5 mg
Product information
Overview
AlphaLISA is a no-wash ELISA alternative and can be used for applications such as:
- Analyte detection assays
- Protein-protein interaction assays
- Protein-DNA interaction assays
- Protein-RNA interaction assays
- Protein-small molecule interaction assays
- Protein detection assays
- Antibody detection assays
- Antibody binding assays
- Immunogenicity assays
- Enzymatic assays
In a typical AlphaLISA assay, 1 mg of Acceptor beads is sufficient to run 1,000-2,000 wells using a 50 µL reaction volume.
Specifications
| Automation Compatible |
Yes
|
|---|---|
| Bead Type or Material |
AlphaLISA Acceptor
|
| Brand |
AlphaLISA
|
| Conjugates |
Unconjugated
|
| Detection Modality |
Alpha
|
| Product Group |
Beads
|
| Shipping Conditions |
Shipped in Blue Ice
|
| Technology |
Alpha
|
| Unit Size |
5 mg
|
Video gallery
AlphaLISA Unconjugated Acceptor Beads, 5 mg
AlphaLISA Unconjugated Acceptor Beads, 5 mg
Resources
Are you looking for resources, click on the resource type to explore further.
Application Note
A fast and simple chemiluminescent assay for monitoring of DNA-protein interactions
Electrophoretic Mobility Shift Assay (EMSA) is a standard technique used to study protein-DNA interactions. It is a radioactive...
Application Note
Development of AlphaLISA technology assays for the detection of neutralizing antibodies in human serum
Administration of biological therapeutics may result in the development of an immune response in patients. It is important that...
Application Note
Immunogenicity assessment using the AlphaLISA technology
Biological drug products often elicit an immune response in patients that can lead to clinical consequences of the presence of...
How can we help you?
We are here to answer your questions.
